Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002264672 | SCV002546418 | likely benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2022-07-05 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.492C>T (p.Val164=) is a synonymous variant. No REVEL score because a synonymous variant and SpliceAI is ≤0.20( 0.01 Donor Loss -16bp and 0.11 Donor Gain 7bp) (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP 1.91014 ≤ 2.0) meeting BP7. In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4 and BP7. |
Labcorp Genetics |
RCV000229993 | SCV000287186 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818593 | SCV002069948 | uncertain significance | not specified | 2019-11-26 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257543 | SCV002535866 | benign | Hereditary cancer-predisposing syndrome | 2020-05-29 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV003316253 | SCV004015364 | likely benign | Acute myeloid leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing |